BioCentury
BioCentury
YouTubeLinkedInXRSS

GCase activator reduces α-synuclein in mouse, patient-derived models of PD

Elizabeth S. Eaton
October 24, 2019 5:31 PM UTC

INDICATION: Parkinson's disease (PD) ...

BCIQ Company Profiles

Lysosomal Therapeutics Inc.

Northwestern University Feinberg School of Medicine

BCIQ Company Profiles

Lysosomal Therapeutics Inc.

Northwestern University Feinberg School of Medicine

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS